Retraction notice to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ EBioMedicine 46 (2019) 66–78

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the editors. Following a request from the authors, the editors of eBioMedicine are retracting the above article. A Corrigendum for the paper was originally issued on May 2020. However, the editors became aware of several potential figure panel duplications between Figure 7c of the paper and Figure 7a of an unrelated manuscript published by Zheng and colleagues, entitled "MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK" Oncotarget. 2017; 8:100227–100241. https://doi.org/10.18632/oncotarget.22151. Given the nature and extent of the image duplications found, the editors of eBioMedicine no longer have confidence in the integrity of the data and retract both the paper and related Corrigendum. RETRACTED: MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathwayThis article has been retracted: please see Elsevier Policy on Article Withdrawal ( https://www.elsevier.com/locate/withdrawalpolicy ). Full-Text PDF Open Access